Methotrexate treatment in patients with a history of cutaneous melanoma and the risk of a consecutive primary melanoma: A national retrospective registry-based cohort study

J Am Acad Dermatol. 2017 Jul;77(1):161-163. doi: 10.1016/j.jaad.2017.02.032.

Authors

Sam Polesie¹, Martin Gillstedt², John Paoli², Amra Osmancevic²

Affiliations

¹ Department of Dermatology and Venereology, Sahlgrenska University Hospital, Institute of Clinical Sciences at the Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden. Electronic address: sam.polesie@vgregion.se.
² Department of Dermatology and Venereology, Sahlgrenska University Hospital, Institute of Clinical Sciences at the Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden.

PMID: 28619553
DOI: 10.1016/j.jaad.2017.02.032

No abstract available

Publication types

Letter
Research Support, Non-U.S. Gov't

MeSH terms

Adult
Aged
Female
Humans
Immunosuppressive Agents / therapeutic use*
Incidence
Male
Melanoma / epidemiology*
Methotrexate / therapeutic use*
Middle Aged
Neoplasms, Second Primary / epidemiology*
Registries
Retrospective Studies
Skin Neoplasms / epidemiology*
Sweden / epidemiology

Substances

Immunosuppressive Agents
Methotrexate